The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

Introduction Interstitial lung disease (ILD) patients may develop a progressive phenotype usually characterised by ...

Researchers found significant sex-based differences in ILD in patients with interdisciplinary indications for complete ...

Baylor Medicine’s Interstitial Lung Disease (ILD) program offers specialized and multidisciplinary care. We bring together a unique team of physicians of multiple sub-specialties for patients with a ...

Zongertinib, an oral therapy shown to have strong responses in patients previously treated for HER2 -mutated non–small cell ...

Scientists have discovered that a rare immune cell type in the lungs, called NAMs, plays a crucial role in surviving COVID-19 ...

interstitial lung disease, and critical care medicine. Serving as a pivotal center for biomedical research, the program significantly contributes to UAB and extends its impact worldwide by addressing ...

Pulmonary sarcoidosis is a lung disease characterized by granulomas—tiny clumps of immune cells that form in response to inflammation. It's the most inflammatory of the interstitial lung ...

Exploratory objectives include assessing its impact on the pathology of the disease ... stated to be affected by the progressive interstitial lung disease, IPF. The disease is characterised ...